Japanese gastric cancer treatment guidelines 2010 (ver. 3)

This publication has 28 references indexed in Scilit:

• Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)
  Gastric Cancer, 2011
• Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer
  Gastric Cancer, 2009
• Therapeutic Value of Lymph Node Dissection in Advanced Gastric Cancer with Macroscopic Duodenum Invasion: Is the Posterior Pancreatic Head Lymph Node Dissection Beneficial?
  Annals of Surgical Oncology, 2009
• Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial
  The Lancet, 2008
• Randomized Controlled Trial Comparing Gastrectomy Plus Chemotherapy with Chemotherapy Alone in Advanced Gastric Cancer with A Single Non-curable Factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01
  Japanese Journal of Clinical Oncology, 2008
• S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
  The Lancet Oncology, 2008
• Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
  New England Journal of Medicine, 2007
• Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic Response
  Journal of Clinical Oncology, 2006
• Value of palliative resection in gastric cancer
  British Journal of Surgery, 2002
• Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer
  British Journal of Cancer, 1995